Develops healthcare products for human genetic resources.
Jun 2026Revenue $12.4K/yrExpenses $1.14M/yr
No trendCash runway ≈ 1 months from Jun 2026
Figures by year
When will Yubo International Biotech be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $12.4K and expenses $1.14M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $12.4K | $1.20M | −$1.19M |
| Dec 2024 | $3.47K | $1.77M | −$1.77M |
| Dec 2023 | $605K | $1.80M | −$1.19M |
| Dec 2022 | $104K | $1.31M | −$1.21M |
| Dec 2021 | $1.24M | $2.79M | −$1.54M |
| Feb 2020 | $0.00 | $29.0K | −$29.0K |
| Feb 2019 | $0.00 | $48.0K | −$48.0K |
| Feb 2018 | $0.00 | $58.0K | −$58.0K |
| Feb 2017 | $0.00 | $149K | −$149K |
| Feb 2016 | $0.00 | $63.0K | −$63.0K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.